Evidence map›Paper›PMID 35457051›Full record

ArticleInternational journal of molecular sciences2022

Heterozygous and Homozygous Variants in

Maria Isabel Alvarez-Mora, Victor Antonio Blanco-Palmero, Juan Francisco Quesada-Espinosa, Ana Rosa Arteche-Lopez, Sara Llamas-Velasco, Carmen Palma Milla, Jose Miguel Lezana Rosales, Irene Gomez-Manjon, Aurelio Hernandez-Lain, Justino Jimenez Almonacid and 12 more

Open access · goldAbstract readCase Reports
In one paragraph

Article in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 12 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. A familial missense variant in the Alzheimer's Disease genebioRxiv : the preprint server for biology · 2023
    Article
  9. Input of exome sequencing in early-onset cerebral amyloid angiopathy.Alzheimer's & dementia (Amsterdam, Netherlands)
    Article
  10. A novelJournal of Alzheimer's disease reports
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 4 institutions in 1 country.

Maria Isabel Alvarez-MoraGenetic Service, Hospital Universitario 12 de Octubre, 28041 Madrid, Spain.ORCID 0000-0003-3788-8915
Victor Antonio Blanco-PalmeroNeurology Department, Hospital Universitario 12 de Octubre, 28041 Madrid, Spain.ORCID 0000-0002-1721-6217
Juan Francisco Quesada-EspinosaGenetic Service, Hospital Universitario 12 de Octubre, 28041 Madrid, Spain.
Ana Rosa Arteche-LopezGenetic Service, Hospital Universitario 12 de Octubre, 28041 Madrid, Spain.
Sara Llamas-VelascoNeurology Department, Hospital Universitario 12 de Octubre, 28041 Madrid, Spain.
Carmen Palma MillaGenetic Service, Hospital Universitario 12 de Octubre, 28041 Madrid, Spain.ORCID 0000-0002-1718-4390
Jose Miguel Lezana RosalesGenetic Service, Hospital Universitario 12 de Octubre, 28041 Madrid, Spain.ORCID 0000-0003-3510-2077
Irene Gomez-ManjonGenetic Service, Hospital Universitario 12 de Octubre, 28041 Madrid, Spain.ORCID 0000-0001-7137-1915
Aurelio Hernandez-LainNeuropathology Unit, Hospital Universitario 12 de Octubre, 28041 Madrid, Spain.
Justino Jimenez AlmonacidNeuropathology Unit, Hospital Universitario 12 de Octubre, 28041 Madrid, Spain.
Belén Gil-FournierGenetic Service, Hospital Universitario de Getafe, 28905 Madrid, Spain.
Soraya Ramiro-LeónGenetic Service, Hospital Universitario de Getafe, 28905 Madrid, Spain.
Marta González-SánchezNeurology Department, Hospital Universitario 12 de Octubre, 28041 Madrid, Spain.
Alejandro Octavio Herrero-San MartínNeurology Department, Hospital Universitario 12 de Octubre, 28041 Madrid, Spain.
David Andrés Pérez-MartínezNeurology Department, Hospital Universitario 12 de Octubre, 28041 Madrid, Spain.ORCID 0000-0001-5587-0415
Estrella Gómez-TortosaNeurology Department, Fundación Jiménez Díaz, 28040 Madrid, Spain.
Eva CarroNetwork Center for Biomedical Research in Neurodegenerative Diseases (CIBERNED), 28031 Madrid, Spain.
Fernando BartoloméNetwork Center for Biomedical Research in Neurodegenerative Diseases (CIBERNED), 28031 Madrid, Spain.ORCID 0000-0001-9322-8933
Maria Jose Gomez-RodriguezGenetic Service, Hospital Universitario 12 de Octubre, 28041 Madrid, Spain.
María Teresa Sanchez-CalvinGenetic Service, Hospital Universitario 12 de Octubre, 28041 Madrid, Spain.
Alberto Villarejo-GalendeNeurology Department, Hospital Universitario 12 de Octubre, 28041 Madrid, Spain.ORCID 0000-0002-6834-7620
Marta Moreno-GarciaGenetic Service, Hospital Universitario 12 de Octubre, 28041 Madrid, Spain.
Hospital Universitario 12 De Octubre · ESResearch Institute Hospital 12 de Octubre · ESHospital Universitario de Getafe · ESHospital Universitario Fundación Jiménez Díaz · ES

Funding

Agency for Administration of University and Research 2017SGR1134Instituto de Salud Carlos III CM 18/0095Instituto de Salud Carlos III JR 18/00046Instituto de Salud Carlos III PI17/01067
6 · The paper itself

Abstract

In the last few years, the SORL1 gene has been strongly implicated in the development of Alzheimer’s disease (AD). We performed whole-exome sequencing on 37 patients with early-onset dementia or family history suggestive of autosomal dominant dementia. Data analysis was based on a custom panel that included 46 genes related to AD and dementia. SORL1 variants were present in a high proportion of patients with candidate variants (15%, 3/20). We expand the clinical manifestations associated with the SORL1 gene by reporting detailed clinical and neuroimaging findings of six unrelated patients with AD and SORL1 mutations. We also present for the first time a patient with the homozygous truncating variant c.364C>T (p.R122*) in SORL1, who also had severe cerebral amyloid angiopathy. Furthermore, we report neuropathological findings and immunochemistry assays from one patient with the splicing variant c.4519+5G>A in the SORL1 gene, in which AD was confirmed by neuropathological examination. Our results highlight the heterogeneity of clinical presentation and familial dementia background of SORL1-associated AD and suggest that SORL1 might be contributing to AD development as a risk factor gene rather than as a major autosomal dominant gene.

Indexed as

Alzheimer DiseaseDementiaGenetic Predisposition to DiseaseHumansLDL-Receptor Related ProteinsMembrane Transport ProteinsNeuroimagingLDL-Receptor Related ProteinsMembrane Transport ProteinsSORL1 protein, humanAlzheimercerebral amyloid angiopathyhomozygous caseSORL1SorLA immunohistochemistry

Identifiers

PMID35457051
PMCPMC9024679
OpenAlexW4223453540

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.